Academic Organizations University Medical Centers COI Policies and Innovation: Talk the Talk but… Thomas Sullivan Apr 21, 2011 0 A small, but vocal group of critics has attempted to dismantle and stigmatize physician-industry relationships for a number of…
State Policy Vermont SB 104 Proposes Additional Changes in “Gift” Ban Rules Thomas Sullivan Apr 20, 2011 0 Almost two years ago, the Vermont Legislature passed (S. 48)—a gift ban and disclosure law which includes all marketing activities…
Congress Senate Special Committee on Aging: FDA and the Reform of the Medical Device… Thomas Sullivan Apr 19, 2011 0 Continuing the ongoing scrutiny surrounding the regulatory environment for medical devices in America, the Senate Aging Committee …
FDA The Scope of Jurisdiction of DDMAC with Pharmaceutical and Device… Thomas Sullivan Apr 18, 2011 0 Recently, the Center for Business Intelligence (CBI) held an Evidenced Based Marketing and Promotion conference. One presentation…
Medical Societies American Rhinologic Society Rational Approach to Relationships with… Thomas Sullivan Apr 15, 2011 0 To encourage innovation and advances in patient care while ensuring integrity, the American Rhinologic Society (ARS) recently…
Academic Organizations Stanford: Clamping Down on Conflicts at the Expense of Innovation Thomas Sullivan Apr 15, 2011 0 Payment data published by ProPublica surrounding industry payments to physicians for educational activities and consulting showed…
CME With Commercial Support Drying Up at University CME Programs —… Thomas Sullivan Apr 14, 2011 1 Over the past several years we have seen a precipitous decline in commercial support of University continuing medical education…
Medical Societies CMSS Submits Comments to HHS-CMS on Sunshine Provisions Thomas Sullivan Apr 13, 2011 0 The Council of Medical Specialty Societies (CMSS), whose 37 member organizations represent 700,000 physicians in the US, recently…
FDA FDA Guidance for Industry Clinical Pharmacogenomics: Premarketing… Thomas Sullivan Apr 13, 2011 0 Pharmacogenomics (PGx) broadly refers to the study of variations of DNA and RNA characteristics as related to drug response. Drug…
Pharmaceutical and Device Small Device Companies Taking Heat for Targeting Marketing But What About… Thomas Sullivan Apr 12, 2011 0 A recent article from the New York Times examined a brand of heart device that patients at a majohospital get. According to the…